Vontobel Holding’s AbbVie ABBV Stock Holding History

Vontobel Holding’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$755K	Buy	+3,000	New	+$645K	﹤0.01%	903

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vontobel Holding's ABBV Position: Q2 2026 in Review

Vontobel Holding increased its AbbVie (ABBV) stake by 16% in Q2 2026, buying an estimated $5.85M and bringing the position to 198,110 shares worth $49.9M. The position accounts for 0.16% of the portfolio, ranked #132.

Vontobel Holding first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. 4,225 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Vontobel Holding held 198,110 shares of AbbVie worth $49.9M as of Q2 2026.
Vontobel Holding bought 27,196 AbbVie shares in Q2 2026, an estimated $5.85M.
AbbVie made up 0.16% of Vontobel Holding's portfolio in Q2 2026, its #132 holding.
Vontobel Holding first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
4,225 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.